» Articles » PMID: 29483265

Expanded Cellular Clones Carrying Replication-competent HIV-1 Persist, Wax, and Wane

Abstract

The latent reservoir for HIV-1 in resting CD4 T cells is a major barrier to cure. Several lines of evidence suggest that the latent reservoir is maintained through cellular proliferation. Analysis of this proliferative process is complicated by the fact that most infected cells carry defective proviruses. Additional complications are that stimuli that drive T cell proliferation can also induce virus production from latently infected cells and productively infected cells have a short in vivo half-life. In this ex vivo study, we show that latently infected cells containing replication-competent HIV-1 can proliferate in response to T cell receptor agonists or cytokines that are known to induce homeostatic proliferation and that this can occur without virus production. Some cells that have proliferated in response to these stimuli can survive for 7 d while retaining the ability to produce virus. This finding supports the hypothesis that both antigen-driven and cytokine-induced proliferation may contribute to the stability of the latent reservoir. Sequencing of replication-competent proviruses isolated from patients at different time points confirmed the presence of expanded clones and demonstrated that while some clones harboring replication-competent virus persist longitudinally on a scale of years, others wax and wane. A similar pattern is observed in longitudinal sampling of residual viremia in patients. The observed patterns are not consistent with a continuous, cell-autonomous, proliferative process related to the HIV-1 integration site. The fact that the latent reservoir can be maintained, in part, by cellular proliferation without viral reactivation poses challenges to cure.

Citing Articles

Blood and tissue HIV-1 reservoirs display plasticity and lack of compartmentalization in virally suppressed people.

Pardons M, Lambrechts L, Noppe Y, Termote L, De Braekeleer S, Vega J Nat Commun. 2025; 16(1):2173.

PMID: 40038305 PMC: 11880387. DOI: 10.1038/s41467-025-57332-5.


The persistent pool of HIV-1-infected cells is formed episodically during untreated infection.

Council O, Tyers L, Moeser M, Sondgeroth A, Spielvogel E, Richardson B J Virol. 2024; 99(2):e0097924.

PMID: 39723838 PMC: 11852786. DOI: 10.1128/jvi.00979-24.


Cognate antigen engagement induces HIV-1 expression in latently infected CD4 T cells from people on long-term antiretroviral therapy.

Moskovljevic M, Dragoni F, Board N, Wu F, Lai J, Zhang H Immunity. 2024; 57(12):2928-2944.e6.

PMID: 39612916 PMC: 11896817. DOI: 10.1016/j.immuni.2024.11.002.


HIV-1 diversity in viral reservoirs obtained from circulating T-cell subsets during early ART and beyond.

Zhang Y, Otte F, Stoeckle M, Thielen A, Daumer M, Kaiser R PLoS Pathog. 2024; 20(9):e1012526.

PMID: 39292732 PMC: 11410260. DOI: 10.1371/journal.ppat.1012526.


Brief Report: Low-Dose Methotrexate Does Not Affect Measures of HIV-1 Persistence in Individuals With Chronically Treated HIV-1 Infection.

Cyktor J, Yeh E, Ribaudo H, Hoeth D, Naqvi A, Bell T J Acquir Immune Defic Syndr. 2024; 96(5):481-485.

PMID: 39287554 PMC: 11408752. DOI: 10.1097/QAI.0000000000003453.


References
1.
Scripture-Adams D, Brooks D, Korin Y, Zack J . Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype. J Virol. 2002; 76(24):13077-82. PMC: 136703. DOI: 10.1128/jvi.76.24.13077-13082.2002. View

2.
Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio F, Yassine-Diab B . HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009; 15(8):893-900. PMC: 2859814. DOI: 10.1038/nm.1972. View

3.
Honeycutt J, Thayer W, Baker C, Ribeiro R, Lada S, Cao Y . HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy. Nat Med. 2017; 23(5):638-643. PMC: 5419854. DOI: 10.1038/nm.4319. View

4.
Chun T, Stuyver L, Mizell S, Ehler L, Mican J, Baseler M . Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A. 1997; 94(24):13193-7. PMC: 24285. DOI: 10.1073/pnas.94.24.13193. View

5.
Havlir D, Strain M, Clerici M, Ignacio C, Trabattoni D, Ferrante P . Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years. J Virol. 2003; 77(20):11212-9. PMC: 224988. DOI: 10.1128/jvi.77.20.11212-11219.2003. View